6/1/2024 | 4:15 PM – 5:45 PM
Retina II: Stamping out Blindness and Restoring Sight / Rétine II: Lutter contre la cécité et redonner la vue
Description
Moderator(s):
Deepa Yoganathan
Wai-Ching Lam
Learning Objectives
At the end of this session, participants will be able to:
1. Update the latest management strategies for retinal vascular disease.
2. Offer ways to improve outcome in managing diabetic macular edema.
3. Connecting retinal findings with systemic implications.
des objectifs d'apprentissage
À la fin de la séance, les participants pourront,
1. Faire une mise à jour sur les dernières stratégies de prise en charge des maladies vasculaires rétiniennes.
2. Proposer des moyens d’améliorer les résultats de la prise en charge de l’œdème maculaire diabétique.
3. Relier les observations rétiniennes aux implications systémiques.
Presentations
Faricimab in Retinal Vein Occlusion: 24-week results from the BALATON and COMINO Trials
04:30 PM - 04:38 PMPresenting Author: Parnian Arjmand
Additional Author(s):
Motohiro Kamei, Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.
Liliana P Paris, Genentech, Inc., South San Francisco, CA, USA.
Francis Abreu, Genentech, Inc., South San Francisco, CA, USA.
Pablo Arrisi, Roche Products Ltd, Welwyn Garden City, UK.
Karen Basu, Roche Products (Ireland), Dublin, Ireland.
Zdenka Haskova, Genentech, Inc., South San Francisco, CA, USA.
Ying Liu, Genentech, Inc., South San Francisco, CA, USA.
Anne-Cecile Retiere, Roche Products Ltd, Welwyn Garden City, UK.
Jeffrey Willis Willis, Genentech, Inc., South San Francisco, CA, USA.
Aachal Korecha, Roche Products Ltd, Welwyn Garden City, UK.
Presenting Author: Peter Kertes
Additional Author(s):
Yuichiro Ogura, Genentech
Gábor Deak, Vienna Reading Center, Medical University of Vienna, Austria
Kara Gibson, Roche Products Ltd., Welwyn Garden City, UK
Ursula Schmidt-Erfurth, Department of Ophthalmology, Medical University of Vienna, Austria.
Tracey Wang, Hoffman-La Roche Pharmaceuticals Canada
Presenting Author: Keyvan Koushan
Additional Author(s):
Clare Bailey, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
David Tabano, Genentech, Inc., South San Francisco, CA, USA
Durga Borkar, Duke University Eye Center, Holly Springs, NC, USA
Vincent Garmo, Genentech, Inc., South San Francisco, CA, USA
Ayesha Ahmed, Genentech, Inc., South San Francisco, CA, USA
Rachel Myers, Verana Health, San Francisco, CA, USA
Andrew LaPrise, Verana Health, San Francisco, CA, USA
Ferhina Ali, Department of Ophthalmology, New York Medical College, Valhalla, NY
Theodore Leng, Verana Health, San Francisco, CA, USA; Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
Rishi P Sing, Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA
The epidemic of Diabetic Retinopathy and Challenges of Loss to Follow-up
04:54 PM - 05:09 PMAflibercept 8 mg for DME: 96-Week Results from the Phase 2/3 PHOTON Trial
05:09 PM - 05:17 PMPresenting Author: Shaheer Aboobaker
Additional Author(s):
Jordan Graff, Barnet Dulaney Perkins Eye Center at American Vision Partners, Phoenix, AZ; University of Arizona, Phoenix; Creighton University, Phoenix, AZ; American Vision Partners, Phoenix, AZ
Dennis Marcus, Southeast Retina Center and Medical College of Georgia, Augusta, GA
Peter Campochiaro, The Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Arshad Khanani, Sierra Eye Associates, Reno, NV, USA
Presenting Author: Michael Balas
Additional Author(s):
Tina Felfeli, Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada
M. Amin Banahashemi, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada
Brian Tan, Rotman Research Institute, Baycrest Health Sciences, Toronto, Canada
Chris Hudson, Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada
Wendy Hatch, Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada
New therapeutic target for optimizing retina ischemic tissue revascularization
05:33 PM - 05:41 PMPresenting Author: Sheetal Pundir
Additional Author(s):
Gael Cagnone, CHU St Justine Hospital, University de Montreal
Jean S. Joyal, CHU St-Justine, Univerity de Montreal
Retina II: Stamping out Blindness and Restoring Sight / Rétine II: Lutter contre la cécité et redonner la vue
Description
Time: 4:15 PM to 5:45 PM
Room: Room | Salle 713 AB
Session Chair: Robert Gizicki, Bernie Hurley